Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Lupin Pharmaceuticals is all set to acquire I'rom Pharmaceutical of Japan, which specializes in speciality injectibles.
Subscribe to our email newsletter
The deal is expected to strengthen Lupin’s presence in the Japanese market.
Lupin president (Asia Pacific, Middle East, Africa and Latin America) Vinod Dhawan said the acquisition would provide them access to $11b market through I’rom’s well established hold in the DPC (diagnosis procedure combination) hospital segment.
The financial details of the acquisition have not been disclosed.